EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer
This study demonstrated that EpCAM-NIR-PIT, particularly when combined with immune-activating agents such as anti-PD-1, is a promising new approach for cancer treatment, inducing durable and systemic anticancer immunity.
Authors
- Aki Furusawa (ORCID: https://orcid.org/0000-0002-1339-4219)
- Peter Choyke
- Hiroshi Yamamoto (ORCID: https://orcid.org/0000-0001-8907-3166)
- Seiichiro Takao (ORCID: https://orcid.org/0000-0002-7920-0763)
- Motofumi Suzuki (ORCID: https://orcid.org/0000-0003-0348-9422)
- Hisataka Kobayashi (ORCID: https://orcid.org/0000-0003-1019-4112)
- Makoto Kano (ORCID: https://orcid.org/0009-0004-7659-1238)
- Miyu Kano
Institutions
- National Cancer Institute (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1080/07853890.2025.2540599
- Citations
- 2
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.04